DE60310605D1 - Nanoteilchen zur verabreichung von wirkstoffen, verfahren zur herstellung dieser teilchen und diese enthaltende zusammensetzung - Google Patents

Nanoteilchen zur verabreichung von wirkstoffen, verfahren zur herstellung dieser teilchen und diese enthaltende zusammensetzung

Info

Publication number
DE60310605D1
DE60310605D1 DE60310605T DE60310605T DE60310605D1 DE 60310605 D1 DE60310605 D1 DE 60310605D1 DE 60310605 T DE60310605 T DE 60310605T DE 60310605 T DE60310605 T DE 60310605T DE 60310605 D1 DE60310605 D1 DE 60310605D1
Authority
DE
Germany
Prior art keywords
particles
administration
compositions
nanote
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60310605T
Other languages
English (en)
Other versions
DE60310605T2 (de
Inventor
Fernandez Maria Jose Alonso
Lopez Carmen Remunan
Vilan Margarita Maria Cuna
Sande Maria Alonso
Jato Jose Luis Vila
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advancell Advanced In Vitro Cell Technologies SA
Original Assignee
Advancell Advanced In Vitro Cell Technologies SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advancell Advanced In Vitro Cell Technologies SA filed Critical Advancell Advanced In Vitro Cell Technologies SA
Application granted granted Critical
Publication of DE60310605D1 publication Critical patent/DE60310605D1/de
Publication of DE60310605T2 publication Critical patent/DE60310605T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60310605T 2002-07-19 2003-07-16 Nanoteilchen zur verabreichung von wirkstoffen, verfahren zur herstellung dieser teilchen und diese enthaltende zusammensetzung Expired - Fee Related DE60310605T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200201694A ES2221530B1 (es) 2002-07-19 2002-07-19 Nanoparticulas para la administracion de ingredientes activos,procedimiento para la elaboracion de dichas particulas y composicion que las contienen.
ES200201694 2002-07-19
PCT/ES2003/000372 WO2004009060A1 (es) 2002-07-19 2003-07-16 Nanopartículas para la administración de ingredientes activos, procedimiento para la elaboración de dichas partículas y composición que las contienen.

Publications (2)

Publication Number Publication Date
DE60310605D1 true DE60310605D1 (de) 2007-02-01
DE60310605T2 DE60310605T2 (de) 2007-09-27

Family

ID=30470576

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60310605T Expired - Fee Related DE60310605T2 (de) 2002-07-19 2003-07-16 Nanoteilchen zur verabreichung von wirkstoffen, verfahren zur herstellung dieser teilchen und diese enthaltende zusammensetzung

Country Status (11)

Country Link
US (1) US20060134785A1 (de)
EP (1) EP1561460B1 (de)
AT (1) ATE348602T1 (de)
CA (1) CA2492995A1 (de)
CY (1) CY1106361T1 (de)
DE (1) DE60310605T2 (de)
DK (1) DK1561460T3 (de)
ES (2) ES2221530B1 (de)
PT (1) PT1561460E (de)
SI (1) SI1561460T1 (de)
WO (1) WO2004009060A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2226567B1 (es) * 2003-06-20 2006-07-01 Universidad De Santiago De Compostela Nanoparticulas de acido hialuronico.
ES2246694B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Nanoparticulas pegiladas.
ES2246695B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
WO2007036946A1 (en) * 2005-09-28 2007-04-05 Padma Venkitachalam Devarajan Compositions for enhanced absorption of biologically active agents
EP1774971A1 (de) * 2005-10-14 2007-04-18 Advanced in Vitro Cell Technologies, S.L. Nanopartikel enthaltend Chitosan und Heparin
WO2007149868A2 (en) * 2006-06-20 2007-12-27 The Regents Of The University Of California Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles
US9173852B2 (en) * 2008-04-08 2015-11-03 Tian Si Polymer Materials Technology Development Co. Glycyrrhetinic acid-mediated nanoparticles of hepatic targeted drug delivery system, process for preparing the same and use thereof
JP5804453B2 (ja) * 2009-05-14 2015-11-04 国立大学法人 東京大学 結晶性ポリオール微粒子及びその調製方法
JP5675798B2 (ja) * 2009-07-09 2015-02-25 ポリマーズ シーアールシー リミテッドＰｏｌｙｍｅｒｓ ＣＲＣ Ｌｔｄ． バイオポリマーハイブリッドゲルデポー送達システム
DE102009048553A1 (de) 2009-09-29 2011-03-31 Carl Zeiss Smt Gmbh Katadioptrisches Projektionsobjektiv mit Umlenkspiegeln und Projektionsbelichtungsverfahren
US8802076B2 (en) * 2010-10-04 2014-08-12 Duke University Compositions and methods for modulating an immune response
JP5903250B2 (ja) * 2011-11-16 2016-04-13 清水化学株式会社 徐放性組成物
KR101372834B1 (ko) * 2011-12-12 2014-03-14 전북대학교산학협력단 하이드로겔 버블 및 이의 제조방법
US9114091B2 (en) * 2013-07-05 2015-08-25 Shimizu Chemical Corporation Sustained release solid dosage preparations
CN107970228A (zh) * 2017-11-02 2018-05-01 天津大学 一种以壳聚糖-tpp-kgm为复合壁材的纳米微囊的制备方法
CN111420067B (zh) * 2020-03-09 2021-08-27 西南交通大学 一种复合微球纳米载体及其制备方法和应用
WO2021209493A2 (en) * 2020-04-15 2021-10-21 Solyplus Gmbh Means and methods of preventing and treating infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2688422A1 (fr) * 1992-03-11 1993-09-17 Coletica Microcapsules a parois en polysaccharides contenant des fonctions alcools primaires, et compositions en contenant.
ES2114502B1 (es) * 1996-07-29 1999-07-01 Univ Santiago Compostela Aplicacion de nanoparticulas a base de polimeros hidrofilicos como formas farmaceuticas.

Also Published As

Publication number Publication date
WO2004009060A1 (es) 2004-01-29
DK1561460T3 (da) 2007-04-30
DE60310605T2 (de) 2007-09-27
EP1561460A1 (de) 2005-08-10
PT1561460E (pt) 2007-03-30
ES2279172T3 (es) 2007-08-16
CY1106361T1 (el) 2011-10-12
CA2492995A1 (en) 2004-01-29
ATE348602T1 (de) 2007-01-15
US20060134785A1 (en) 2006-06-22
ES2221530B1 (es) 2006-02-16
ES2221530A1 (es) 2004-12-16
EP1561460B1 (de) 2006-12-20
SI1561460T1 (sl) 2007-06-30

Similar Documents

Publication Publication Date Title
DE60310605D1 (de) Nanoteilchen zur verabreichung von wirkstoffen, verfahren zur herstellung dieser teilchen und diese enthaltende zusammensetzung
Husain et al. Chitosan biomaterials for current and potential dental applications
ATE536855T1 (de) Gewebegerüste zusamensetzungen zur behandlung von zahnerkrankungen
ATE213164T1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
ATE396967T1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
BRPI0519195A2 (pt) composiÇço de cuidado oral, e, mÉtodo para prevenir ou tratar cÁrie dental em um indivÍduo humano ou animal
DE602005010733D1 (de) Ophthalmische emulsion mit einem immunosuppressiven mittel
HUP0302114A2 (hu) Eritropoietin-fehérjét tartalmazó folyékony gyógyászati készítmény, eljárás előállítására és alkalmazása
WO2005020928A3 (en) Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
EP1393734A4 (de) Arzneimittel gegen darmerkrankungen
CA2317465A1 (en) Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same
WO2004067027A3 (en) Osteogenic composition
BRPI0417415A (pt) composições comestìveis que estão adaptadas para uso por um animal de estimação
DE60140191D1 (de) Zusammensetzungen mit matrixproteinen zur regeneration von dentin
MXPA05013270A (es) Forma de administracion transmucosal con irritacion mucosal reducida. reducida.
BG105275A (en) Tan-1057 derivatives
ATE245445T1 (de) Suspension enthaltend ein epi-hne protein, verfahren zu ihrer herstellung, daraus hergestelltes trockenpulveraerosol, arzneimittelzusammensetzungen enthaltend diese suspension oder dieses aerosol und ihre verwendungen
RS11104A (en) Combined preparations,containing 1,4- benzothiepine-1,1- dioxide derivatives and other active substances, and the use thereof
DE602006010111D1 (de) Pharmazeutische formulierung zur behandlung von osteoarthritis mit clodronsäure und hyaluronsäure
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
WO2002058532A3 (en) Method for identifying ligands to lxr-receptor that stimulates pre-adipocyte differentiation and formulations thereof
ATE404192T1 (de) Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration
RU2006109966A (ru) Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных
DE50310932D1 (de) Sporopollenin enthaltende lösliche zusammensetzung und verwendung
DE602004025103D1 (de) Heilkräuterzusammensetzung zur Behandlung von AIDS

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee